World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
26131
World Ranking
15086
National Ranking
7617

Overview

Issa F. Khouri is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research is primarily focused on medicine, with a significant concentration in hematology, public health, environmental and occupational health, oncology, genetics, and pathology and forensic medicine.

Their work covers a range of main topics, including:

  • Acute Lymphoblastic Leukemia research
  • Hematopoietic Stem Cell Transplantation
  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research

Khouri has contributed extensively to academic literature, with notable recent papers such as:

  • "Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results," American Journal of Hematology, 2023
  • "Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia," Blood, 2021
  • "Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors," Cancer, 2021
  • "Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL," Blood, 2020
  • "Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial," The Lancet Haematology, 2020

The frequent co-authors collaborating with Khouri include:

  • Partow Kebriaei
  • Richard E. Champlin
  • Uday Popat
  • Elizabeth J. Shpall
  • Muzaffar H. Qazilbash

Their work has been published predominantly in several journals, with the most common venues being:

  • Blood
  • Transplantation and Cellular Therapy
  • Bone Marrow Transplantation
  • Clinical Lymphoma Myeloma & Leukemia
  • American Journal of Hematology

Best Publications

  • Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

    Sergio Giralt;Elihu Estey;Maher Albitar;Koen Van Besien

  • Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

    I F Khouri;M Keating;M Körbling;D Przepiorka

  • Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

    Sergio Giralt;Peter F. Thall;Issa Khouri;Xuemei Wang

  • Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

    Issa F. Khouri;Rima M. Saliba;Sergio A. Giralt;Ming Sheng Lee

  • CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation

    S. Giralt;J. Hester;Yang O Huh;Cheryl F Hirsch-Ginsberg

  • Double hit lymphoma: the MD Anderson Cancer Center clinical experience.

    Yasuhiro Oki;Mansoor Noorani;Pei Lin;Richard E. Davis

  • Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.

    I F Khouri;J Romaguera;H Kantarjian;J L Palmer

  • Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.

    Issa F Khouri;Peter McLaughlin;Rima M Saliba;Chitra Hosing

  • Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

    D. Przepiorka;N. A. Kernan;C. Ippoliti;E. B. Papadopoulos

  • Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.

    N T Ueno;G Rondón;N Q Mirza;D K Geisler

  • Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation

    Apostolia Maria Tsimberidou;Susan O'Brien;Issa Khouri;Francis J. Giles

  • Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.

    M. de Lima;J. McMannis;A. Gee;K. Komanduri

  • Extracorporeal photochemotherapy for the treatment of steroid resistant chronic GVHD

    Daniel R. Couriel;Chitra Hosing;Rima M Saliba;Elizabeth Shpall

  • Tumor necrosis factor-α blockade for the treatment of acute GVHD

    Daniel Couriel;Rima Saliba;Krystal Hicks;Cindy Ippoliti

  • Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation

    Donna Przepiorka;Donna Przepiorka;Terry L. Smith;Jody Folloder;Issa F Khouri

  • Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

    Donna Przepiorka;Paolo Anderlini;Rima M Saliba;Karen Cleary

  • Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

    Stefan Octavian Ciurea;Victor Eduardo Mulanovich;Rima M Saliba;Ulas D. Bayraktar

  • Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

    Richard E Champlin;Issa F Khouri;Avichai Shimoni;James Gajewski

  • Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.

    Antonio Di Stasi;Denái R. Milton;L.M. Poon;Amir Hamdi

  • Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

    K. W. Van Besien;M. De Lima;S. A. Giralt;D. F. Moore

Frequent Co-Authors

Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Partow Kebriaei
Partow Kebriaei The University of Texas MD Anderson Cancer Center
Borje S. Andersson
Borje S. Andersson The University of Texas MD Anderson Cancer Center
Elizabeth J. Shpall
Elizabeth J. Shpall The University of Texas MD Anderson Cancer Center
Elias Jabbour
Elias Jabbour The University of Texas MD Anderson Cancer Center
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Donna Przepiorka
Donna Przepiorka US Food and Drug Administration
Luis Fayad
Luis Fayad The University of Texas MD Anderson Cancer Center
Susan O'Brien
Susan O'Brien University of California, Irvine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA offers a variety of educational pathways beyond traditional medical school. Many healthcare professionals build rewarding careers by pursuing specialized degrees online, which provide flexibility and accessibility.

Registered nurses wishing to advance can consider adn to msn bridge programs to fast-track their move into leadership or advanced clinical roles. For those who prefer minimal clinical requirements, there are also best online rn to bsn programs without clinical requirements that focus on theory-based learning and professional growth.

Healthcare isn't limited to direct patient care. Those interested in the business and management side can pursue cahme accredited mha online programs, which prepare graduates for hospital administration and leadership positions.

For individuals passionate about healthy living and disease prevention, an online degree in nutrition opens doors to careers in wellness, public health, or clinical nutrition.

Best Scientists Citing Issa F. Khouri

Trending Scientists

Recently Published Articles